Invention Grant
- Patent Title: Ophthalmic illumination system with controlled chromaticity
-
Application No.: US15620159Application Date: 2017-06-12
-
Publication No.: US10400967B2Publication Date: 2019-09-03
- Inventor: Ronald T. Smith
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Main IPC: A61B1/06
- IPC: A61B1/06 ; F21S10/02 ; H01S3/08 ; H01S3/00 ; A61B90/30 ; F21V9/40 ; A61F9/007

Abstract:
An ophthalmic illumination system includes a light source to emit a light beam and a filter comprising a clear region to transmit visible light in the visible spectrum and a first filtered region to transmit visible light in a first spectral range. The filter is arranged within the optical path of the beam. The system includes a plurality of chromaticity sensors to receive a portion of the light beam transmitted by the filter and output a signal indicating chromaticity of the received beam. The system also includes a processor to receive the signal indicating chromaticity, compare the indicated chromaticity to a target chromaticity stored in memory and, based on the comparison, adjust the chromaticity of the light beam transmitted by the filter by generating a signal to move the filter from a first position in which the light beam is incident upon only the clear region to a second position in which the light beam is partially incident on both the clear region and the first filtered region.
Public/Granted literature
- US20170356608A1 OPHTHALMIC ILLUMINATION SYSTEM WITH CONTROLLED CHROMATICITY Public/Granted day:2017-12-14
Information query